Pearl River Capital’s Nuvation Bio NUVB Stock Holding History

Pearl River Capital’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,441	Closed	-$107K	–	515
2021 Q2	$107K	Buy	+11,441	New	+$130K	0.03%	401

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Pearl River Capital's NUVB Position: Q3 2021 in Review

Pearl River Capital sold out of Nuvation Bio (NUVB) in Q3 2021, closing a stake of 11,441 shares — an estimated $107K sold.

Pearl River Capital first reported a position in NUVB in Q2 2021 and held it in 1 quarter. The position peaked at $107K in Q2 2021. 98 funds tracked by Wall St. Rank hold NUVB as of Q3 2021.

Pearl River Capital reported no remaining Nuvation Bio position as of Q3 2021 after selling out during the quarter.
Pearl River Capital sold 11,441 Nuvation Bio shares in Q3 2021, an estimated $107K.
Pearl River Capital first reported a position in Nuvation Bio in Q2 2021 and held it in 1 quarter.
Pearl River Capital's Nuvation Bio position peaked at $107K in Q2 2021.
98 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2021.

Based on Pearl River Capital's 13F filing for Q3 2021, filed 12 Nov 2021.